AAAAAA
Results:
1-14
|
Results: 14
Authors:
Magen, D
Oliven, A
Shechter, Y
Elhasid, R
Bar-Joseph, G
Zelikovic, I
Citation: D. Magen et al., Plasmapheresis in a very young infant with atypical hemolytic uremic syndrome, PED NEPHROL, 16(1), 2001, pp. 87-90
Authors:
Cohen, D
Shechter, Y
Slatkine, M
Gatt, N
Perez, R
Citation: D. Cohen et al., Laser myringotomy in different age groups, ARCH OTOLAR, 127(3), 2001, pp. 260-264
Authors:
Shechter, Y
Goldwaser, I
Lavon, I
Gershonov, E
Mester, B
Mironchik, M
Patt, LP
Fridkin, M
Citation: Y. Shechter et al., A new approach for prolonging the half-life of peptides, proteins and low-molecular-weight drugs in vivo, DRUG FUTURE, 26(7), 2001, pp. 669-676
Authors:
Oliven, A
Shechter, Y
Citation: A. Oliven et Y. Shechter, Extracorporeal photopheresis: a review, BLOOD REV, 15(2), 2001, pp. 103-108
Authors:
Shechter, Y
Preciado-Patt, L
Schreiber, G
Fridkin, M
Citation: Y. Shechter et al., Prolonging the half-life of human interferon-alpha 2 in circulation: Design, preparation, and analysis of (2-sulfo-9-fluorenylmethoxycarbonyl)(7)-interferon-alpha 2, P NAS US, 98(3), 2001, pp. 1212-1217
Authors:
Carter, A
Dann, EJ
Katz, T
Shechter, Y
Oliven, A
Regev, R
Eytan, E
Rowe, JM
Eytan, GD
Citation: A. Carter et al., Cells from chronic myelogenous leukaemia patients at presentation exhibit multidrug resistance not mediated by either MDR1 or MRP1, BR J HAEM, 114(3), 2001, pp. 581-590
Authors:
Elhasid, R
Ben Arush, MW
Katz, T
Gan, Y
Shechter, Y
Sami, I
Postovsky, S
Reisner, Y
Rowe, JM
Citation: R. Elhasid et al., Successful haploidentical bone marrow transplantation in Fanconi anemia, BONE MAR TR, 26(11), 2000, pp. 1221-1223
Authors:
Sun, Q
Sekar, N
Goldwaser, I
Gershonov, E
Fridkin, M
Shechter, Y
Citation: Q. Sun et al., Vanadate restores glucose 6-phosphate in diabetic rats: a mechanism to enhance glucose metabolism, AM J P-ENDO, 279(2), 2000, pp. E403-E410
Authors:
Goldwaser, I
Gefel, D
Gershonov, E
Fridkin, M
Shechter, Y
Citation: I. Goldwaser et al., Insulin-like effects of vanadium: basic and clinical implications, J INORG BIO, 80(1-2), 2000, pp. 21-25
Authors:
Goldwaser, I
Qian, S
Gershonov, E
Fridkin, M
Shechter, Y
Citation: I. Goldwaser et al., Organic vanadium chelators potentiate vanadium-evoked glucose metabolism in vitro and in vivo: Establishing criteria for optimal chelators, MOLEC PHARM, 58(4), 2000, pp. 738-746
Authors:
Gershonov, E
Goldwaser, I
Fridkin, M
Shechter, Y
Citation: E. Gershonov et al., A novel approach for a water soluble long-acting insulin prodrug: Design, preparation, and analysis of [(2-sulfo)-9-fluorenylmethoxycarbonyl](3)-insulin, J MED CHEM, 43(13), 2000, pp. 2530-2537
Authors:
Goldwaser, I
Li, JP
Gershonov, E
Armoni, M
Karnieli, E
Fridkin, M
Shechter, Y
Citation: I. Goldwaser et al., L-glutamic acid gamma-monohydroxamate - A potentiator of vanadium-evoked glucose metabolism in vitro and in vivo, J BIOL CHEM, 274(37), 1999, pp. 26617-26624
Authors:
Sekar, N
Li, JP
He, ZB
Gefel, D
Shechter, Y
Citation: N. Sekar et al., Independent signal-transduction pathways for vanadate and for insulin in the activation of glycogen synthase and glycogenesis in rat adipocytes, ENDOCRINOL, 140(3), 1999, pp. 1125-1131
Authors:
Gershonov, E
Shechter, Y
Fridkin, M
Citation: E. Gershonov et al., New concept for long-acting insulin - Spontaneous conversion of an inactive modified insulin to the active hormone in circulation: 9-fluorenylmethoxycarbonyl derivative of insulin, DIABETES, 48(7), 1999, pp. 1437-1442
Risultati:
1-14
|